News from cellectis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 27, 2014, 12:00 ET Cellectis will be Present at the ASCO Annual Meeting

André Choulika, PhD, CEO of Cellectis (Alternext: ALCLS) and Mathieu Simon, MD, Executive Vice President will be attending this year's ASCO meeting...


Sep 26, 2011, 12:00 ET The ETICS Project, Led by CYTOO in Collaboration With Cellectis bioresearch and the CEA, to Receive Euro 7.6 Million in Funding From OSEO

CYTOO, a company that specializes in cell-based assays (Grenoble, France), has joined up with Cellectis bioresearch, the specialist in genome...


Sep 06, 2011, 12:00 ET Cellectis to Present at Two Upcoming International Investor Conferences

Cellectis (Alternext: ALCLS), the French genome engineering specialist, will present at the UBS Global Life Sciences Conference in New York City on...


Jul 20, 2011, 12:00 ET Cellectis Bioresearch and Lonza Achieve Significant Milestone on CHO-K1SV GS Knock-Out

Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of Cellectis (Alternext: ALCLS), and Lonza, a world leader in...


Jul 11, 2011, 12:00 ET Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis therapeutics

Cellectis therapeutics, a subsidiary of Cellectis (Alternext: ALCLS) specializing in the development of therapeutic applications in genome...


Jul 05, 2011, 12:00 ET TALEN® Access by Cellectis Bioresearch Receives "Most Innovative New Service 2011" Award at Life Science Awards

Cellectis bioresearch, a subsidiary of Cellectis (Alternext: ALCLS) and specialist in genome customization, has received the "Most Innovative New...


Jun 29, 2011, 12:00 ET Cellectis and Pregenen Sign Collaboration Agreement for the Development of Meganucleases

Cellectis (Alternext: ALCLS), the French genome engineering specialist, announced today the signing of a collaboration agreement with Pregenen, an...


Jun 06, 2011, 12:00 ET Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection

Cellectis (Alternext: ALCLS), the genome engineering specialist, and VitamFero, a biotech company of the Genopole® portfolio developing new vaccines...


May 18, 2011, 12:00 ET Cellectis bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan

Cellectis bioresearch, a subsidiary of Cellectis (Alternext: ALCLS) and genome customization specialist, has appointed Wako Pure Chemical Industries...


Apr 11, 2011, 12:00 ET Cellectis Strengthens Management Team to Support Stem Cell Activities

Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced today the recruitment of three senior managers to support the...


Apr 05, 2011, 12:00 ET Cellectis and Caisse des Depots Sign Agreement on a Project for the Industrial Development of iPS Cells

Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced today that its subsidiary Ectycell has signed an agreement with the...


Apr 04, 2011, 12:00 ET Cellectis Receives Payment for License to Homologous Recombination Patents

Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced today that it has signed a license agreement with a pharmaceutical...


Mar 31, 2011, 02:30 ET Cellectis Publishes 2010 Financial Results

Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced its consolidated financial results for the financial year ended...


Mar 08, 2011, 12:00 ET Cellectis and the Etablissement Francais du Sang Launch StemRed, a Program to Produce Red Blood Cells From Stem Cells

Cellectis (Alternext: ALCLS), the genome engineering specialist, and Etablissement Francais du Sang (EFS), the only civilian blood transfusion...


Dec 02, 2010, 02:00 ET Cellectis Grants Harvard Bioscience a License to CytoPulse Electroporation Instruments

Cellectis (Alternext: ALCLS), the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), ...


Nov 30, 2010, 02:00 ET Cellectis Hosts Inaugural R&D Day

Cellectis (Alternext: ALCLS), the French genome engineering specialist, will today host an R&D day for investors, analysts and the media at its...


Nov 04, 2010, 03:00 ET Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice

Cellectis plant sciences, the plant genome engineering specialist and subsidiary of Cellectis (Alternext: ALCLS), announced today that it has signed...


Oct 25, 2010, 02:00 ET Cellectis and the Center for iPS Cells Research and Application Enter Collaboration

Cellectis (Alternext: ALCLS), the French genome engineering specialist, and the Center for iPS Cells Research and Application (CiRA) of Kyoto...


Oct 19, 2010, 02:01 ET Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds

Cellectis plant sciences, the plant genome engineering specialist and subsidiary of Cellectis (Alternext: ALCLS), announced today that it has signed...


Oct 18, 2010, 02:00 ET Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan

Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have...


Oct 15, 2010, 02:00 ET Cellectis Publishes Its Financial Statement for the First Half of 2010

Cellectis (Alternext: ALCLS), the French genome engineering specialist, today published its consolidated financial statement for the half-year ending ...


Oct 13, 2010, 02:00 ET Cellectis bioresearch Announces Establishment of Subsidiary in the US

Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), today announced that it has established a ...


Oct 07, 2010, 02:00 ET Cellectis to Present at the Annual Congress of the European Society of Gene & Cell Therapy

Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces today that Julianne Smith, PhD, head of the Meganuclease...


Sep 27, 2010, 02:00 ET Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store

Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), is pleased to announce the launch of...


Sep 22, 2010, 08:40 ET Cellectis Unveils Its New Corporate Website

Cellectis (Alternext: ALCLS), the French genome engineering specialist, has announced the launch of its new corporate website. Visitors to this new...